AAAAAA

   
Results: 1-7 |
Results: 7
Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients
Authors: Minniti, G Moroni, C Jaffrain-Rea, ML Esposito, V Santoro, A Affricano, C Cantore, G Tamburrano, G Cassone, R
Citation: G. Minniti et al., Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients, CLIN ENDOCR, 55(3), 2001, pp. 307-313
Relationship between blood pressure and glucose tolerance in acromegaly
Authors: Jaffrain-Rea, ML Moroni, C Baldelli, R Battista, C Maffei, P Terzolo, M Correra, M Ghiggi, MR Ferretti, E Angeli, A Sicolo, N Trischitta, V Liuzzi, A Cassone, R Tamburrano, G
Citation: Ml. Jaffrain-rea et al., Relationship between blood pressure and glucose tolerance in acromegaly, CLIN ENDOCR, 54(2), 2001, pp. 189-195
Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg)
Authors: Baldelli, R Colao, A Razzore, P Jaffrain-Rea, ML Marzullo, P Ciccarelli, E Ferretti, E Ferone, D Gaia, D Camanni, F Lombardi, G Tamburrano, G
Citation: R. Baldelli et al., Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg), J CLIN END, 85(11), 2000, pp. 4099-4103
p16 (INK4(a), MTS-1) gene polymorphism and methylation status in human pituitary tumours
Authors: Jaffrain-Rea, ML Ferretti, E Toniato, E Cannita, K Santoro, A Di Stefano, D Ricevuto, E Maroder, M Tamburrano, G Cantore, G Gulino, A Martinotti, S
Citation: Ml. Jaffrain-rea et al., p16 (INK4(a), MTS-1) gene polymorphism and methylation status in human pituitary tumours, CLIN ENDOCR, 51(3), 1999, pp. 317-325
Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective study
Authors: Razzore, P Colao, A Baldelli, R Gaia, D Marzullo, P Ferretti, E Ferone, D Jaffrain-Rea, ML Tamburrano, G Lombardi, G Camanni, F Ciccarelli, E
Citation: P. Razzore et al., Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective study, CLIN ENDOCR, 51(2), 1999, pp. 159-164
Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism
Authors: Ferretti, E Persani, L Jaffrain-Rea, ML Giambona, S Tamburrano, G Beck-Peccoz, P
Citation: E. Ferretti et al., Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism, J CLIN END, 84(3), 1999, pp. 924-929
Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients
Authors: Baldelli, R Ferretti, E Jaffrain-Rea, ML Iacobellis, G Minniti, G Caracciolo, B Moroni, C Cassone, R Gulino, A Tamburrano, G
Citation: R. Baldelli et al., Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients, J CLIN END, 84(2), 1999, pp. 527-532
Risultati: 1-7 |